A British Society for Haematology good practice paper: Recommendations for laboratory testing of UK patients with acute myeloid leukaemia

被引:4
|
作者
Mehta, Priyanka [1 ]
Telford, Nick [2 ]
Wragg, Chris [3 ]
Dillon, Richard [4 ]
Freeman, Sylvie [5 ]
Finnegan, Damian [6 ]
Hamblin, Angela [7 ]
Copland, Mhairi [8 ]
Knapper, Steve [9 ]
机构
[1] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England
[2] Christie NHS Fdn Trust, Oncol Cytogenet, Manchester, Lancs, England
[3] North Bristol NHS Trust, Bristol Genet Lab, Westbury On Trym, England
[4] Kings Coll London, Dept Med & Mol Genet, Canc Genet Lab, London, England
[5] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[6] Belfast City Hosp, Dept Haematol, Belfast, Antrim, North Ireland
[7] Oxford Univ Hosp NHS Fdn Trust & Genom, NIHR Oxford Biomed Res Ctr, Oxford, England
[8] Univ Glasgow, Coll Med Vet & Life Sci, Paul OGorman Leukaemia Res Ctr, Sch Canc Sci, Glasgow, Lanark, Scotland
[9] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, Wales
关键词
cytogenetics; flow cytometry; leukaemia diagnosis; molecular genetics; myeloid leukaemia; HEALTH-ORGANIZATION CLASSIFICATION; RESIDUAL DISEASE; RISK;
D O I
10.1111/bjh.18516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:150 / 159
页数:10
相关论文
共 50 条
  • [41] AN EVALUATION OF THE TYROSINE KINASE INHIBITOR PACRITINIB IN PATIENTS WITH RELAPSED FLT3-MUTATED ACUTE MYELOID LEUKAEMIA (THE UK NCRI AML17 STUDY)
    Knapper, S.
    Grech, A.
    Cahalin, P.
    Kaur, H.
    Mehta, P.
    Richardson, D.
    Taussig, D.
    Hills, R.
    Burnett, A.
    Russell, N.
    HAEMATOLOGICA, 2016, 101 : 40 - 40
  • [42] Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
    Lisa Pleyer
    Sonja Burgstaller
    Reinhard Stauder
    Michael Girschikofsky
    Heinz Sill
    Konstantin Schlick
    Josef Thaler
    Britta Halter
    Sigrid Machherndl-Spandl
    Armin Zebisch
    Angelika Pichler
    Michael Pfeilstöcker
    Eva-Maria Autzinger
    Alois Lang
    Klaus Geissler
    Daniela Voskova
    Dietmar Geissler
    Wolfgang R. Sperr
    Sabine Hojas
    Inga M. Rogulj
    Johannes Andel
    Richard Greil
    Journal of Hematology & Oncology, 9
  • [43] Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 31, pg 697, 2020)
    Heuser, M.
    Ofran, Y.
    Boissel, N.
    Mauri, S. Brunet
    Craddock, C.
    Janssen, J.
    Wierzbowska, A.
    Buske, C.
    ANNALS OF ONCOLOGY, 2021, 32 (06) : 821 - 821
  • [44] Family building using donated gametes and embryos in the UK: Recommendations for policy and practice on behalf of the British Infertility Counselling Association and the British Fertility Society in collaboration with the Association of Clinical Embryologists and the Royal College of Nurses Fertility Nurses Forum
    Wilde, Ruth
    McTavish, Alison
    Crawshaw, Marilyn
    HUMAN FERTILITY, 2014, 17 (01) : 1 - 10
  • [45] Maintaining Life-saving Testing for Patients With Infectious Diseases: Infectious Diseases Society of America, American Society for Microbiology, and Pan American Society for Clinical Virology Recommendations on the Regulation of Laboratory-developed Tests
    Caliendo, Angela M.
    Couturier, Marc R.
    Ginocchio, Christine C.
    Hanson, Kimberly E.
    Miller, Melissa B.
    Walker, Kimberly E.
    Frank, Gregory M.
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (02) : 151 - 154
  • [46] Antecedent Conformity of Diagnostic and Molecular Testing Patterns in Clinical Practice for Newly Diagnosed Acute Myeloid Leukemia With American Society of Hematology and College of American Pathologists Guidelines
    George, Tracy
    Foucar, Kathryn
    Pollyea, Daniel
    Erba, Harry
    Thompson, Michael
    Roboz, Gail
    Pagel, John
    Cogle, Christopher
    Nifenecker, Melissa
    Swern, Arlene
    Kiselev, Pavel
    Sugrue, Mary
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S82 - S83
  • [47] Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)
    C. Kahl
    R. Krahl
    C. Becker
    H. K. Al-Ali
    H. G. Sayer
    A. Schulze
    M. Herold
    M. Hänel
    S. Scholl
    A. Hochhaus
    L. Uharek
    G. Maschmeyer
    D. Haehling
    C. Junghanß
    N. Peter
    D. Kämpfe
    E. Kettner
    T. Heinicke
    T. Fischer
    U. Kreibich
    H.-H. Wolf
    D. Niederwieser
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 305 - 315
  • [48] Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)
    Kahl, C.
    Krahl, R.
    Becker, C.
    Al-Ali, H. K.
    Sayer, H. G.
    Schulze, A.
    Herold, M.
    Haenel, M.
    Scholl, S.
    Hochhaus, A.
    Uharek, L.
    Maschmeyer, G.
    Haehling, D.
    Junghanss, C.
    Peter, N.
    Kaempfe, D.
    Kettner, E.
    Heinicke, T.
    Fischer, T.
    Kreibich, U.
    Wolf, H. -H.
    Niederwieser, D.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 305 - 315
  • [49] Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
    Canaani, Jonathan
    Labopin, Myriam
    Huang, Xiao J.
    Ciceri, Fabio
    Van Lint, Maria T.
    Bruno, Benedetto
    Santarone, Stella
    Diez-Martin, Jose L.
    Blaise, Didier
    Chiusolo, Patrizia
    Wu, Depei
    Mohty, Mohamad
    Nagler, Arnon
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 411 - 420
  • [50] An analysis of the cost savings achieved through practice of vial sharing for patients on azacitidine (Vidaza®) treatment for myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML with 10-29% blasts) and acute myeloid leukaemia (AML with 20-30% blasts) in a district general hospital (DGH) haematology unit over a 2 years period
    Bartlett, M.
    Thomas, T.
    Hughes, J.
    Grubb, H.
    Kundu, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 123 - 124